Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy

Genomics

Volumn 94, Issue 1, 2009, Pages 20-31

  Colak, Dilek ^a   Kaya, Namik ^a   Al Zahrani, Jawaher ^a   Al Bakheet, Albandary ^a   Muiya, Paul ^a   Andres, Editha ^a   Quackenbush, John ^b   Dzimiri, Nduna ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Apoptotic signaling; Gene up down regulation; Global gene expression; Idiopathic dilated cardiomyopathy; Microarray gene expression; Mitochondrial function

Indexed keywords

CITRIC ACID; ECALECTIN; HISTONE DEACETYLASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PEROXIREDOXIN 2;

ADULT; ALZHEIMER DISEASE; ANGIOGENESIS; APOPTOSIS; ARTICLE; CATALYSIS; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE PROBE; GENETIC ASSOCIATION; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS;

APOPTOSIS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CITRIC ACID CYCLE; DOWN-REGULATION; GENE EXPRESSION PROFILING; HEART VENTRICLES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 67349234089     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.03.003     Document Type: Article

References (93)

1. Arimura T., Hayashi T., and Kimura A. Molecular etiology of idiopathic cardiomyopathy. Acta Myol. 26 3 (2007) 153-158
2. Ross Jr. J. Dilated cardiomyopathy: concepts derived from gene deficient and transgenic animal models. Circ. J. 66 3 (2002) 219-224
3. Chang A.N., and Potter J.D. Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail. Rev. 10 3 (2005) 225-235
4. Granzier H., Wu Y., Siegfried L., and LeWinter M. Titin: physiological function and role in cardiomyopathy and failure. Heart Fail. Rev. 10 3 (2005) 211-223
5. Ahmad F., Seidman J.G., and Seidman C.E. The genetic basis for cardiac remodeling. Annu. Rev. Genomics Hum. Genet. 6 (2005) 185-216
6. Sutton M.G., and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101 25 (2000) 2981-2988
7. Wolff M.R., Buck S.H., Stoker S.W., Greaser M.L., and Mentzer R.M. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J. Clin. Invest. 98 1 (1996) 167-176
8. Dzimiri N. Regulation of beta-adrenoceptor signaling in cardiac function and disease. Pharmacol. Rev. 51 3 (1999) 465-501
9. Mittmann C., Eschenhagen T., and Scholz H. Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc. Res. 39 2 (1998) 267-275
10. Periasamy M., and Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 35 4 (2007) 430-442
11. Solaro R.J., and Rarick H.M. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ. Res. 83 5 (1998) 471-480
12. Palmer B.M. Thick filament proteins and performance in human heart failure. Heart Fail. Rev. 10 3 (2005) 187-197
13. Layland J., Solaro R.J., and Shah A.M. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc. Res. 66 1 (2005) 12-21
14. Sivakumar P., Gupta S., Sarkar S., and Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol. Cell. Biochem. 307 1-2 (2008) 159-167
15. Escobales N., and Crespo M.J. Early pathophysiological alterations in experimental cardiomyopathy: the Syrian cardiomyopathic hamster. P. R. Health Sci. J. 27 4 (2008) 307-314
16. McCloskey D.T., Turcato S., Wang G.Y., Turnbull L., Zhu B.Q., Bambino T., Nguyen A.P., Lovett D.H., Nissenson R.A., Karliner J.S., and Baker A.J. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 294 1 (2008) H205-212
17. Mahmoudabady M., Mathieu M., Dewachter L., Hadad I., Ray L., Jespers P., Brimioulle S., Naeije R., and McEntee K. Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy. J. Card. Fail. 14 8 (2008) 703-709
18. Princen F., Bard E., Sheikh F., Zhang S.S., Wang J., Zago W.M., Wu D., Trelles R.D., Bailly-Maitre B., Kahn C.R., Chen Y., Reed J.C., Tong G.G., Mercola M., Chen J., and Feng G.S. Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death. Mol. Cell. Biol. 29 2 (2009) 378-388
19. Zheng M., Cheng H., Li X., Zhang J., Cui L., Ouyang K., Han L., Zhao T., Gu Y., Dalton N.D., Bang M.L., Peterson K.L., and Chen J. Cardiac-specific ablation of cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum. Mol. Genet. (2008)
20. Birks E.J., Latif N., Enesa K., Folkvang T., Luong le A., Sarathchandra P., Khan M., Ovaa H., Terracciano C.M., Barton P.J., Yacoub M.H., and Evans P.C. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc. Res. 79 3 (2008) 472-480
21. Tavi P., Laine M., Weckstrom M., and Ruskoaho H. Cardiac mechanotransduction: from sensing to disease and treatment. Trends Pharmacol. Sci. 22 5 (2001) 254-260
22. Barth A.S., Kuner R., Buness A., Ruschhaupt M., Merk S., Zwermann L., Kaab S., Kreuzer E., Steinbeck G., Mansmann U., Poustka A., Nabauer M., and Sultmann H. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J. Am. Coll. Cardiol. 48 8 (2006) 1610-1617
23. Yung C.K., Halperin V.L., Tomaselli G.F., and Winslow R.L. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83 2 (2004) 281-297
24. Barrans J.D., Allen P.D., Stamatiou D., Dzau V.J., and Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am. J. Pathol. 160 6 (2002) 2035-2043
25. Kaab S., Barth A.S., Margerie D., Dugas M., Gebauer M., Zwermann L., Merk S., Pfeufer A., Steinmeyer K., Bleich M., Kreuzer E., Steinbeck G., and Nabauer M. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J. Mol. Med. 82 5 (2004) 308-316
26. Kittleson M.M., Minhas K.M., Irizarry R.A., Ye S.Q., Edness G., Breton E., Conte J.V., Tomaselli G., Garcia J.G., and Hare J.M. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics 21 3 (2005) 299-307
27. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., and Slikker Jr. W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24 9 (2006) 1151-1161
28. Guo L., Lobenhofer E.K., Wang C., Shippy R., Harris S.C., Zhang L., Mei N., Chen T., Herman D., Goodsaid F.M., Hurban P., Phillips K.L., Xu J., Deng X., Sun Y.A., Tong W., Dragan Y.P., and Shi L. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 24 9 (2006) 1162-1169
29. Ali-Seyed M., Laycock N., Karanam S., Xiao W., Blair E.T., and Moreno C.S. Cross-platform expression profiling demonstrates that SV40 small tumor antigen activates Notch, Hedgehog, and Wnt signaling in human cells. BMC Cancer 6 (2006) 54
30. Walker S.J., Wang Y., Grant K.A., Chan F., and Hellmann G.M. Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates. J. Neurosci. Methods 152 1-2 (2006) 179-189
31. Wang Y., Barbacioru C., Hyland F., Xiao W., Hunkapiller K.L., Blake J., Chan F., Gonzalez C., Zhang L., and Samaha R.R. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7 (2006) 59
32. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
33. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., and Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5 10 (2004) R80
34. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57 (1995) 289-300
35. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 9 (2001) 5116-5121
36. Li C., and Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2 8 (2001) RESEARCH0032
37. Wu Z., and Irizarry R.A. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J. Comput. Biol. 12 6 (2005) 882-893
38. Wu Z., and Irizarry R.A. Preprocessing of oligonucleotide array data. Nat. Biotechnol. 22 6 (2004) 656-658 author reply 658
39. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 2 (2003) 374-378
40. Sherman B.T., Huang D.W., Tan Q., Guo Y., Bour S., Liu D., Stephens R., Baseler M.W., Lane H.C., and Lempicki R.A. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics 8 1 (2007) 426
41. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 10 (2003) R70
42. Thomas P.D., Kejariwal A., Campbell M.J., Mi H., Diemer K., Guo N., Ladunga I., Ulitsky-Lazareva B., Muruganujan A., Rabkin S., Vandergriff J.A., and Doremieux O. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic. Acids Res. 31 1 (2003) 334-341
43. Thomas P.D., Kejariwal A., Guo N., Mi H., Campbell M.J., Muruganujan A., and Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic. Acids Res. 34 (2006) W645-650 (Web Server issue)
44. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., and Lemischka I.R. A stem cell molecular signature. Science 298 5593 (2002) 601-604
45. Dudoit S.S.P., and Boldrick J.C. Multiple hypothesis testing in microarray experiments. Statist. Sci. 18 1 (2003) 71-103
46. Pedotti P., t Hoen P.A., Vreugdenhil E., Schenk G.J., Vossen R.H., Ariyurek Y., de Hollander M., Kuiper R., van Ommen G.J., den Dunnen J.T., Boer J.M., and de Menezes R.X. Can subtle changes in gene expression be consistently detected with different microarray platforms?. BMC Genomics 9 (2008) 124
47. Chuang L.Y., Ke C.H., Chang H.W., and Yang C.H. A two-stage feature selection method for gene expression data. Omics (2009)
48. Barrett A.B., Phan J.H., and Wang M.D. Combining multiple microarray studies using bootstrap meta-analysis. Conf. Proc. IEEE. Eng. Med. Biol. Soc. 1 (2008) 5660-5663
49. Francois P., Garzoni C., Bento M., and Schrenzel J. Comparison of amplification methods for transcriptomic analyses of low abundance prokaryotic RNA sources. J. Microbiol. Methods 68 2 (2007) 385-391
50. Dzimiri N., Afrane B., and Canver C.C. Preferential existence of death-inducing proteins in the human cardiomyopathic left ventricle. J. Surg. Res. (2007)
51. Dzimiri N., Muiya P., Andes E., and Afrane B. Differential regulation of myocyte death/survival signalling in human dilated cardiomyopathy. FASEB J. 20 (2006) 164
52. Steenbergen C., Afshari C.A., Petranka J.G., Collins J., Martin K., Bennett L., Haugen A., Bushel P., and Murphy E. Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am. J. Physiol. Heart Circ. Physiol. 284 1 (2003) H268-276
53. Takeishi Y., Huang Q., Abe J., Che W., Lee J.D., Kawakatsu H., Hoit B.D., Berk B.C., and Walsh R.A. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc. Res. 53 1 (2002) 131-137
54. Plenz G., Song Z.F., Reichenberg S., Tjan T.D., Robenek H., and Deng M.C. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac. Cardiovasc. Surg. 46 4 (1998) 213-216
55. Hwang J.J., Allen P.D., Tseng G.C., Lam C.W., Fananapazir L., Dzau V.J., and Liew C.C. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics 10 1 (2002) 31-44
56. Grzeskowiak R., Witt H., Drungowski M., Thermann R., Hennig S., Perrot A., Osterziel K.J., Klingbiel D., Scheid S., Spang R., Lehrach H., and Ruiz P. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc. Res. 59 2 (2003) 400-411
57. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., and Molkentin J.D. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281 14 (2006) 9152-9162
58. LeWinter M.M. Functional consequences of sarcomeric protein abnormalities in failing myocardium. Heart Fail. Rev. 10 3 (2005) 249-257
59. Lopes R., Solter P.F., Sisson D.D., Oyama M.A., and Prosek R. Characterization of canine mitochondrial protein expression in natural and induced forms of idiopathic dilated cardiomyopathy. Am. J. Vet. Res. 67 6 (2006) 963-970
60. Portman M.A. The adenine nucleotide translocator: regulation and function during myocardial development and hypertrophy. Clin. Exp. Pharmacol. Physiol. 29 4 (2002) 334-338
61. Dorner A., Giessen S., Gaub R., Grosse Siestrup H., Schwimmbeck P.L., Hetzer R., Poller W., and Schultheiss H.P. An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy. Eur. J. Heart Fail. 8 1 (2006) 81-89
62. Margulies K.B., Matiwala S., Cornejo C., Olsen H., Craven W.A., and Bednarik D. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ. Res. 96 5 (2005) 592-599
63. Hannenhalli S., Putt M.E., Gilmore J.M., Wang J., Parmacek M.S., Epstein J.A., Morrisey E.E., Margulies K.B., and Cappola T.P. Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114 12 (2006) 1269-1276
64. Grau S., Baldi A., Bussani R., Tian X., Stefanescu R., Przybylski M., Richards P., Jones S.A., Shridhar V., Clausen T., and Ehrmann M. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc. Natl. Acad. Sci. U. S. A. 102 17 (2005) 6021-6026
65. Yang Z., Camp N.J., Sun H., Tong Z., Gibbs D., Cameron D.J., Chen H., Zhao Y., Pearson E., Li X., Chien J., Dewan A., Harmon J., Bernstein P.S., Shridhar V., Zabriskie N.A., Hoh J., Howes K., and Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 5801 (2006) 992-993
66. Carta F., Demuro P.P., Zanini C., Santona A., Castiglia D., D'Atri S., Ascierto P.A., Napolitano M., Cossu A., Tadolini B., Turrini F., Manca A., Sini M.C., Palmieri G., and Rozzo A.C. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res. 15 4 (2005) 235-244
67. Furuta J., Nobeyama Y., Umebayashi Y., Otsuka F., Kikuchi K., and Ushijima T. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res. 66 12 (2006) 6080-6086
68. Oka C., Tsujimoto R., Kajikawa M., Koshiba-Takeuchi K., Ina J., Yano M., Tsuchiya A., Ueta Y., Soma A., Kanda H., Matsumoto M., and Kawaichi M. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131 5 (2004) 1041-1053
69. Vahsen N., Cande C., Briere J.J., Benit P., Joza N., Larochette N., Mastroberardino P.G., Pequignot M.O., Casares N., Lazar V., Feraud O., Debili N., Wissing S., Engelhardt S., Madeo F., Piacentini M., Penninger J.M., Schagger H., Rustin P., and Kroemer G. AIF deficiency compromises oxidative phosphorylation. EMBO J. 23 23 (2004) 4679-4689
70. Urbano A., Lakshmanan U., Choo P.H., Kwan J.C., Ng P.Y., Guo K., Dhakshinamoorthy S., and Porter A. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J. 24 15 (2005) 2815-2826
71. Delettre C., Yuste V.J., Moubarak R.S., Bras M., Robert N., and Susin S.A. Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH oxidase activity. J. Biol. Chem. 281 27 (2006) 18507-18518
72. Sanchez-Font M.F., Sebastia J., Sanfeliu C., Cristofol R., Marfany G., and Gonzalez-Duarte R. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell. Mol. Life Sci. 60 7 (2003) 1513-1523
73. Yao J., Taylor M., Davey F., Ren Y., Aiton J., Coote P., Fang F., Chen J.X., Yan S.D., and Gunn-Moore F.J. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell. Neurosci. 35 2 (2007) 377-382
74. Huang E., Cheng S.H., Dressman H., Pittman J., Tsou M.H., Horng C.F., Bild A., Iversen E.S., Liao M., Chen C.M., West M., Nevins J.R., and Huang A.T. Gene expression predictors of breast cancer outcomes. Lancet 361 9369 (2003) 1590-1596
75. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., and Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 6905 (2002) 367-374
76. Chikamori K., Hill J.E., Grabowski D.R., Zarkhin E., Grozav A.G., Vaziri S.A., Wang J., Gudkov A.V., Rybicki L.R., Bukowski R.M., Yen A., Tanimoto M., Ganapathi M.K., and Ganapathi R. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest. Leukemia 20 10 (2006) 1809-1818
77. Mousses S., Bubendorf L., Wagner U., Hostetter G., Kononen J., Cornelison R., Goldberger N., Elkahloun A.G., Willi N., Koivisto P., Ferhle W., Raffeld M., Sauter G., and Kallioniemi O.P. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res. 62 5 (2002) 1256-1260
78. Abedin M.J., Kashio Y., Seki M., Nakamura K., and Hirashima M. Potential roles of galectins in myeloid differentiation into three different lineages. J. Leukoc. Biol. 73 5 (2003) 650-656
79. Kasamatsu A., Uzawa K., Nakashima D., Koike H., Shiiba M., Bukawa H., Yokoe H., and Tanzawa H. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int. J. Mol. Med. 16 2 (2005) 269-273
80. Okudaira T., Hirashima M., Ishikawa C., Makishi S., Tomita M., Matsuda T., Kawakami H., Taira N., Ohshiro K., Masuda M., Takasu N., and Mori N. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines. Int. J. Cancer 120 10 (2007) 2251-2261
81. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102 10 (2005) 3627-3632
82. Koed K., Wiuf C., Christensen L.L., Wikman F.P., Zieger K., Moller K., von der Maase H., and Orntoft T.F. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Res. 65 1 (2005) 34-45
83. Zimmermann S., Kiefer F., Prudenziati M., Spiller C., Hansen J., Floss T., Wurst W., Minucci S., and Gottlicher M. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67 19 (2007) 9047-9054
84. Tateno T., Izumiyama H., Doi M., Yoshimoto T., Shichiri M., Inoshita N., Oyama K., Yamada S., and Hirata Y. Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. Eur. J. Endocrinol. 157 6 (2007) 717-724
85. Steenman M., Chen Y.W., Le Cunff M., Lamirault G., Varro A., Hoffman E., and Leger J.J. Transcriptomal analysis of failing and nonfailing human hearts. Physiol. Genomics 12 2 (2003) 97-112
86. Lou H., Danelisen I., and Singal P.K. Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 288 4 (2005) H1925-1930
87. Bueno O.F., and Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91 9 (2002) 776-781
88. Larkin J.E., Frank B.C., Gaspard R.M., Duka I., Gavras H., and Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol. Genomics 18 2 (2004) 152-166
89. Su B., Wang X., Nunomura A., Moreira P.I., Lee H.G., Perry G., Smith M.A., and Zhu X. Oxidative stress signaling in Alzheimer's disease. Curr. Alzheimer Res. 5 6 (2008) 525-532
90. Fukui H., and Moraes C.T. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?. Trends Neurosci. 31 5 (2008) 251-256
91. Arbuzova S., Hutchin T., and Cuckle H. Mitochondrial dysfunction and Down's syndrome. Bioessays. 24 8 (2002) 681-684
92. Tan F.L., Moravec C.S., Li J., Apperson-Hansen C., McCarthy P.M., Young J.B., and Bond M. The gene expression fingerprint of human heart failure. Proc. Natl. Acad. Sci. U. S. A. 99 17 (2002) 11387-11392
93. Ikeda S., Kong S.W., Lu J., Bisping E., Zhang H., Allen P.D., Golub T.R., Pieske B., and Pu W.T. Altered microRNA expression in human heart disease. Physiol. Genomics (2007)